BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3024816)

  • 1. Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3.
    Eisman JA; Barkla DH; Tutton PJ
    Cancer Res; 1987 Jan; 47(1):21-5. PubMed ID: 3024816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Shot Local Injection of Microfragmented Fat Tissue Loaded with Paclitaxel Induces Potent Growth Inhibition of Hepatocellular Carcinoma in Nude Mice.
    Alessandri G; Pessina A; Paroni R; Bercich L; Paino F; Dei Cas M; Cadei M; Caruso A; Schiariti M; Restelli F; Zeira O; Tremolada C; Portolani N
    Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reviewing the Significance of Vitamin D Substitution in Monoclonal Gammopathies.
    Innao V; Allegra A; Ginaldi L; Pioggia G; De Martinis M; Musolino C; Gangemi S
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic Estimation Models-based Approach to Predict Clinical Implications for CYP Induction by Calcitriol in Human Cryopreserved Hepatocytes and HepaRG Cells.
    Chae YJ; Kim MS; Chung SJ; Lee MK; Lee KR; Maeng HJ
    Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33572963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 25-Hydroxyvitamin D status, vitamin D intake, and skin cancer risk: a systematic review and dose-response meta-analysis of prospective studies.
    Mahamat-Saleh Y; Aune D; Schlesinger S
    Sci Rep; 2020 Aug; 10(1):13151. PubMed ID: 32753685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical evolution for taming the 'pathogenic kinase' PAK1.
    Maruta H; Kittaka A
    Drug Discov Today; 2020 Jun; 25(6):959-964. PubMed ID: 32348877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAK1-blockers: Potential Therapeutics against COVID-19.
    Maruta H; He H
    Med Drug Discov; 2020 Jun; 6():100039. PubMed ID: 32313880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of Vitamin D in Melanoma Development, Progression and Therapy.
    Brożyna AA; Hoffman RM; Slominski AT
    Anticancer Res; 2020 Jan; 40(1):473-489. PubMed ID: 31892603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial.
    Ng K; Nimeiri HS; McCleary NJ; Abrams TA; Yurgelun MB; Cleary JM; Rubinson DA; Schrag D; Miksad R; Bullock AJ; Allen J; Zuckerman D; Chan E; Chan JA; Wolpin BM; Constantine M; Weckstein DJ; Faggen MA; Thomas CA; Kournioti C; Yuan C; Ganser C; Wilkinson B; Mackintosh C; Zheng H; Hollis BW; Meyerhardt JA; Fuchs CS
    JAMA; 2019 Apr; 321(14):1370-1379. PubMed ID: 30964527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin cancer and vitamin D: an update.
    Wyatt C; Neale RE; Lucas RM
    Melanoma Manag; 2015 Feb; 2(1):51-61. PubMed ID: 30190831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival.
    Orlow I; Shi Y; Kanetsky PA; Thomas NE; Luo L; Corrales-Guerrero S; Cust AE; Sacchetto L; Zanetti R; Rosso S; Armstrong BK; Dwyer T; Venn A; Gallagher RP; Gruber SB; Marrett LD; Anton-Culver H; Busam K; Begg CB; Berwick M;
    Pigment Cell Melanoma Res; 2018 Mar; 31(2):287-296. PubMed ID: 28990310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,25D
    Ma Y; Luo W; Bunch BL; Pratt RN; Trump DL; Johnson CS
    Oncotarget; 2017 Sep; 8(36):60080-60093. PubMed ID: 28947955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BsmI (rs1544410) and FokI (rs2228570) vitamin D receptor polymorphisms, smoking, and body mass index as risk factors of cutaneous malignant melanoma in northeast Italy.
    Cauci S; Maione V; Buligan C; Linussio M; Serraino D; Stinco G
    Cancer Biol Med; 2017 Aug; 14(3):302-318. PubMed ID: 28884047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial.
    De Smedt J; Van Kelst S; Boecxstaens V; Stas M; Bogaerts K; Vanderschueren D; Aura C; Vandenberghe K; Lambrechts D; Wolter P; Bechter O; Nikkels A; Strobbe T; Emri G; Marasigan V; Garmyn M
    BMC Cancer; 2017 Aug; 17(1):562. PubMed ID: 28835228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management.
    Slominski AT; Brożyna AA; Zmijewski MA; Jóźwicki W; Jetten AM; Mason RS; Tuckey RC; Elmets CA
    Lab Invest; 2017 Jun; 97(6):706-724. PubMed ID: 28218743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative Effects of 1α-OH-vitD
    Spath L; Ulivieri A; Lavra L; Fidanza L; Carlesimo M; Giubettini M; Narcisi A; Luciani E; Bucci B; Pisani D; Sciacchitano S; Bartolazzi A
    Sci Rep; 2017 Jan; 7():40370. PubMed ID: 28074906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D and Physical Activity in Patients With Colorectal Cancer: Epidemiological Evidence and Therapeutic Implications.
    Morales-Oyarvide V; Meyerhardt JA; Ng K
    Cancer J; 2016; 22(3):223-31. PubMed ID: 27341603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Vitamin D Levels With Outcome in Patients With Melanoma After Adjustment For C-Reactive Protein.
    Fang S; Sui D; Wang Y; Liu H; Chiang YJ; Ross MI; Gershenwald JE; Cormier JN; Royal RE; Lucci A; Wargo J; Hu MI; Gardner JM; Reveille JD; Bassett RL; Wei Q; Amos CI; Lee JE
    J Clin Oncol; 2016 May; 34(15):1741-7. PubMed ID: 27001565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants in the vitamin D pathway genes VDBP and RXRA modulate cutaneous melanoma disease-specific survival.
    Yin J; Liu H; Yi X; Wu W; Amos CI; Fang S; Lee JE; Han J; Wei Q
    Pigment Cell Melanoma Res; 2016 Mar; 29(2):176-85. PubMed ID: 26575331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based study.
    Orlow I; Reiner AS; Thomas NE; Roy P; Kanetsky PA; Luo L; Paine S; Armstrong BK; Kricker A; Marrett LD; Rosso S; Zanetti R; Gruber SB; Anton-Culver H; Gallagher RP; Dwyer T; Busam K; Begg CB; Berwick M;
    Carcinogenesis; 2016 Jan; 37(1):30-8. PubMed ID: 26521212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.